Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale
|
July 1, 1989
[New therapeutic prospects in acute acoustic trauma]
P Blotta, M Turrini, A Pastore, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale
|
January 1, 1993
[Bisyllabic words for speech audiometry: a new italian material]
M Turrini, F Cutugno, P Maturi, et al.
Plos One
|
October 22, 2016
Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia
Kristina R Kesely, Antonella Pantaleo, Francesco M Turrini, et al.
Cancer Investigation
|
August 31, 2006
Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study
B Neri, L Vannozzi, C Fulignati, et al.
The Journal of Experimental Medicine
|
August 26, 2021
Imatinib augments standard malaria combination therapy without added toxicity
Huynh Dinh Chien, Antonella Pantaleo, Kristina R Kesely, et al.
Anticancer Research
|
January 18, 2003
Gemcitabine plus Epi-doxorubicin as first-line chemotherapy for bladder cancer in advanced or metastatic stage: a phase II
B Neri, L Doni, C Fulignati, et al.
Blood
|
June 22, 2017
Syk inhibitors interfere with erythrocyte membrane modification during <i>P falciparum</i> growth and suppress parasite egress
Antonella Pantaleo, Kristina R Kesely, Maria Carmina Pau, et al.
The Journal of Urology
|
August 21, 2002
Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer
B Neri, L Doni, M T Gemelli, et al.
Anti-Cancer Drugs
|
December 23, 2004
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma: report of a phase II trial
B Neri, G Cipriani, C Fulignati, et al.
Arquivos De Neuro-Psiquiatria
|
April 19, 2000
[The most frequent neurologic disturbances. A contribution to the definition of topics for the programmatic content to the program of neurology in medical graduation]
J E Ferri-De-Barros, J C Veiga, A V Priante, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale
|
July 1, 1989
[New therapeutic prospects in acute acoustic trauma]
P Blotta, M Turrini, A Pastore, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale
|
January 1, 1993
[Bisyllabic words for speech audiometry: a new italian material]
M Turrini, F Cutugno, P Maturi, et al.
Plos One
|
October 22, 2016
Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia
Kristina R Kesely, Antonella Pantaleo, Francesco M Turrini, et al.
Cancer Investigation
|
August 31, 2006
Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study
B Neri, L Vannozzi, C Fulignati, et al.
The Journal of Experimental Medicine
|
August 26, 2021
Imatinib augments standard malaria combination therapy without added toxicity
Huynh Dinh Chien, Antonella Pantaleo, Kristina R Kesely, et al.
Anticancer Research
|
January 18, 2003
Gemcitabine plus Epi-doxorubicin as first-line chemotherapy for bladder cancer in advanced or metastatic stage: a phase II
B Neri, L Doni, C Fulignati, et al.
Blood
|
June 22, 2017
Syk inhibitors interfere with erythrocyte membrane modification during <i>P falciparum</i> growth and suppress parasite egress
Antonella Pantaleo, Kristina R Kesely, Maria Carmina Pau, et al.
The Journal of Urology
|
August 21, 2002
Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer
B Neri, L Doni, M T Gemelli, et al.
Anti-Cancer Drugs
|
December 23, 2004
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma: report of a phase II trial
B Neri, G Cipriani, C Fulignati, et al.
Arquivos De Neuro-Psiquiatria
|
April 19, 2000
[The most frequent neurologic disturbances. A contribution to the definition of topics for the programmatic content to the program of neurology in medical graduation]
J E Ferri-De-Barros, J C Veiga, A V Priante, et al.
Page
of 3